Dataset from A Pilot Study to Assess the Efficacy of Rituximab Therapy in Patients With Treatment Resistant Idiopathic Focal Segmental Glomerulosclerosis (FSGS): Integrating an Assessment of the Relevance of suPAR and Activation of Podocyte β3 Integrin
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/PR00008540
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to determine whether Rituximab therapy is safe and effective in
treating patients with the kidney condition, focal segmental glomerulosclerosis (FSGS), that
is no longer responsive to traditional therapies.
创建时间：
2026-02-06
